In last trading session, Metagenomi Inc (NASDAQ:MGX) saw 0.35 million shares changing hands with its beta currently measuring -1.31. Company’s recent per share price level of $1.94 trading at $0.03 or 1.57% at ring of the bell on the day assigns it a market valuation of $72.60M. That closing price of MGX’s stock is at a discount of -511.34% from its 52-week high price of $11.86 and is indicating a premium of 17.01% from its 52-week low price of $1.61. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.32 million shares which gives us an average trading volume of 1.14 million if we extend that period to 3-months.
For Metagenomi Inc (MGX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.25. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.78 in the current quarter.
Metagenomi Inc (NASDAQ:MGX) trade information
Upright in the green during last session for gaining 1.57%, in the last five days MGX remained trading in the red while hitting it’s week-highest on Monday, 03/10/25 when the stock touched $1.94 price level, adding 7.4% to its value on the day. Metagenomi Inc’s shares saw a change of -46.26% in year-to-date performance and have moved -6.28% in past 5-day. Metagenomi Inc (NASDAQ:MGX) showed a performance of -18.83% in past 30-days. Number of shares sold short was 2.65 million shares which calculate 4.79 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 14.5 to the stock, which implies a rise of 86.62% to its current value. Analysts have been projecting 7 as a low price target for the stock while placing it at a high target of 22. It follows that stock’s current price would drop -260.82% in reaching the projected high whereas dropping to the targeted low would mean a loss of -260.82% for stock’s current value.
Metagenomi Inc (MGX) estimates and forecasts
This year revenue growth is estimated to rise 15.51% from the last financial year’s standing.
5 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 9.46M for the same. And 2 analysts are in estimates of company making revenue of 6.25M in the next quarter. Company posted 12.4M and 11.16M of sales in current and next quarters respectively a year earlier.
In 2025, company’s earnings growth rate is likely to be around 87.64% while estimates for its earnings growth in next 5 years are of 50.88%.
Metagenomi Inc (NASDAQ:MGX)’s Major holders
Insiders are in possession of 28.80% of company’s total shares while institution are holding 28.73 percent of that, with stock having share float percentage of 40.35%. Investors also watch the number of corporate investors in a company very closely, which is 28.73% institutions for Metagenomi Inc that are currently holding shares of the company.
On the other hand, iShares Russell 2000 ETF and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 618.66 shares of worth $1.2 million or 1.65% of the total outstanding shares. The later fund manager was in possession of 484.25 shares on Dec 31, 2024 , making its stake of worth around $0.94 million in the company or a holder of 1.29% of company’s stock.
